Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AGALSIDASE BETA Cause Incorrect product administration duration? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Incorrect product administration duration have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 0.1% of all adverse event reports for AGALSIDASE BETA.

6
Reports of Incorrect product administration duration with AGALSIDASE BETA
0.1%
of all AGALSIDASE BETA reports
0
Deaths
1
Hospitalizations

How Dangerous Is Incorrect product administration duration From AGALSIDASE BETA?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does AGALSIDASE BETA Cause?

Malaise (409) Pain (395) Pyrexia (362) Fatigue (338) Nausea (303) Weight decreased (272) Headache (269) Dyspnoea (266) Chills (259) Vomiting (244)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which AGALSIDASE BETA Alternatives Have Lower Incorrect product administration duration Risk?

AGALSIDASE BETA vs AGOMELATINE AGALSIDASE BETA vs ALAWAY AGALSIDASE BETA vs ALBENDAZOLE AGALSIDASE BETA vs ALBIGLUTIDE AGALSIDASE BETA vs ALBUMIN

Related Pages

AGALSIDASE BETA Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration AGALSIDASE BETA Demographics